Patent · US Expired

Method for chemoprevention of prostate cancer

US6632447B1 · kind B1 · utility

26Cited by
15References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 8, 2000
Grant dateOct 14, 2003
Priority date
Expiry dateNov 8, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to the chemoprevention of prostate cancer and, more particularly, to a method of suppressing or inhibiting latent prostate cancer comprising administering to a mammalian subject a chemopreventive agent and analogs and metabolites thereof. The chemopreventive agent prevents, prevents recurrence of, suppresses or inhibit prostate carcinogenesis; and treats prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.